Alginate graft copolymers and alginate-co-excipient physical mixture in oral drug delivery

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 12, 2011, Pages 1497-1512

  Wong, Tin Wui ^a  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

alginate; co excipient; graft copolymer; oral drug delivery

Indexed keywords

ALGINIC ACID; AMINOSALICYLIC ACID; COPOLYMER; DAUNORUBICIN; EXCIPIENT;

COVALENT BOND; CROSS LINKING; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; HYDROPHILICITY; HYDROPHOBICITY; INTERMETHOD COMPARISON; ORAL DRUG ADMINISTRATION; PHYSICAL CHEMISTRY; POROSITY; REVIEW; WATER ABSORPTION;

ADMINISTRATION, ORAL; ALGINATES; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; POLYMERS; RATS;

EID: 80855139575     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01347.x     Document Type: Review

References (151)

1. George M, Abraham TE,. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Controlled Release 2006; 114: 1-14. (Pubitemid 44131680)
2. Khotimchenko YS, Khotimchenko MY,. Healing and preventive effects of calcium alginate on carbon tetrachloride induced liver injury in rats. Mar Drugs 2004; 2: 108-122.
3. et al. Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnol Genet Eng Rev 1999; 16: 23-40.
4. Draget KI, Taylor C,. Chemical, physical and biological properties of alginates and their biomedical implications. Food Hydrocolloids 2011; 25: 251-256.
5. Sankalia MG, et al,. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha amylase: optimization and physicochemical characterization. Eur J Pharm Biopharm 2007; 65: 215-232. (Pubitemid 46038077)
6. Sabra W, et al,. Bacterial alginates: physiology, product quality and process aspects. Appl Microbiol Biotechnol 2001; 56: 315-325. (Pubitemid 32768594)
7. Vos PD, et al,. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006; 27: 5603-5617.
8. Zimmermann H, et al,. Alginate-based encapsulation of cells: pat, present and future. Curr Diab Rep 2007; 7: 314-320. (Pubitemid 47249091)
9. Gao C, et al,. Preparation of oxidized sodium alginate-graft-poly(2- dimethylamino) ethyl methacrylate gel beads and in vitro controlled release behavior of BSA. Int J Pharm 2009; 371: 16-24.
10. Rastello De Boisseson M, et al,. Physical alginate hydrogels based on hydrophobic or dual hydrophobic/ionic interactions: bead formation, structure, and stability. J Colloid Interface Sci 2004; 273: 131-139.
11. González-Rodríguez ML, et al,. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm 2002; 232: 225-234. (Pubitemid 34076768)
12. Segal HC, et al,. The effects of alginate and non-alginate wound dressings on blood coagulation and platelet activation. J Biomater Appl 1998; 12: 249-257. (Pubitemid 128593648)
13. Chen S-C, et al,. A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate crosslinked by genipin for protein drug delivery. J Controlled Release 2004; 96: 285-300. (Pubitemid 38481510)
14. Yang L, et al,. Amphiphilic cholesteryl grafted sodium alginate derivative: synthesis and self-assembly in aqueous solution. Carbohydr Polym 2007; 68: 218-225. (Pubitemid 46329116)
15. Yao B, et al,. Hydrophobic modification of sodium alginate and its application in drug controlled release. Bioprocess Biosyst Eng 2010; 33: 457-463.
16. Kametani N, et al,. Effects of a mixing tea drink containing depolymerized sodium alginate on serum total cholesterol and assessment of its safety. Jpn Pharmacol Ther 2007; 35: 1133-1147. (Pubitemid 350306432)
17. Kimura Y, et al,. Effects of soluble sodium alginate on cholesterol excretion and glucose tolerance in rats. J Ethnopharmacol 1996; 54: 47-54. (Pubitemid 26379876)
18. Kuda T, et al,. Effects of dietary concentration of Laminaran and depolymerised alginate on rat cecal microflora and plasma lipids. Fish Sci 1998; 64: 589-593. (Pubitemid 128439357)
19. Paxman JR, et al,. Alginate reduces the increased uptake of cholesterol and glucose in overweight male subjects: a pilot study. Nutr Res 2008; 28: 501-505. (Pubitemid 352004080)
20. Sandberg AS, et al,. Alginate, small bowel sterol excretion, and absorption of nutrients in ileostomy subjects. Am J Clin Nutr 1994; 60: 751-756.
21. Seal CJ, Mathers JC,. Comparative gastrointestinal and plasma cholesterol responses of rats fed on cholesterol-free diets and supplemented with guar gum and sodium alginate. Brit J Nutr 2001; 85: 317-324. (Pubitemid 32293760)
22. Wang W, et al,. Effects of alginate viscosity on digestibility and lipid metabolism in rats. Nippon Suisan Gakk 2003; 69: 72-79. (Pubitemid 38370408)
23. Chaki T, et al,. Dose dependency of sodium alginate oligosaccharides in a randomized double-blind placebo-controlled clinical study in subjects with high normal blood pressure and mild hypertension. Jpn Pharmacol Ther 2006; 34: 1267-1277. (Pubitemid 46065372)
24. Chaki T, et al,. Hypotensive response and safety of long term sodium alginate oligosaccharides intake in subjects with high normal blood pressure and mild hypertension. Jpn Pharmacol Ther 2007; 35: 519-531. (Pubitemid 47014033)
25. Chen Y-Y, et al,. Preventive effects of low molecular mass potassium alginate extracted from brown algae on DOCA salt-induced hypertension in rats. Biomed Pharmacother 2010; 64: 291-295.
26. Torsdottir I, et al,. A small dose of soluble alginate-fiber affects postprandial glycemia and gastric emptying in humans with diabetes. J Nutr 1991; 121: 795-799.
27. An Q-D, et al,. Alginate-deriving oligosaccharide production by alginase from newly isolated Flavobacterium sp. LXA and its potential application in protection against pathogens. J Appl Microbiol 2009; 106: 161-170.
28. Al-Shamkhani A, Duncan R,. Synthesis, controlled release properties and antitumour activity of alginate-cis-aconityl-daunomycin conjugates. Int J Pharm 1995; 122: 107-119.
29. Lee W-R, et al,. The biological effects of topical alginate treatment in an animal model of skin wound healing. Wound Repair Regen 2009; 17: 505-510.
30. Schmidt RJ, et al,. Biocompatibility of wound management products: a study of the effects of various polysaccharides on murine L929 fibroblasts proliferation and macrophage respiratory burst. J Pharm Pharmacol 1993; 45: 508-513. (Pubitemid 23201430)
31. Sen G, et al,. Microwave-initiated synthesis of polyacrylamide grafted sodium alginate: synthesis and characterization. J Appl Polym Sci 2010; 115: 63-71.
32. Braga AS, et al,. Quantitative analysis of potentially toxic metals in alginates for dental use. Rev Ciênc Farm Básica Apl 2005; 26: 125-130. (Pubitemid 43970472)
33. 2+ ions: a dynamic and equilibrium study. J Appl Polym Sci 2007; 103: 2581-2590.
34. Höllriegl V, et al,. Strontium biokinetics in humans: influence of alginate on the uptake of ingested strontium. Health Phys 2004; 86: 193-196. (Pubitemid 38112601)
35. Nayak D, Lahiri S,. Biosorption of toxic, heavy, no-carrier-added radionuclides by calcium alginate beads. J Radioanal Nucl Chem 2006; 267: 59-65.
36. Tomoda M, Inokuchi K,. Sodium alginate of lowered polymerization (alginon). A new plasma expander. J Int Coll Surg 1959; 32: 621-635.
37. Harjoh N, Wong TW,. Design of in-situ dispersible and calcium crosslinked alginate pellets as intestinal-specific drug carrier by melt pelletization technique. J Pharm Sci 2011; 100: 2248-2257.
38. Bürger C, et al,. Chitosan-alginate capsules as oral delivery system for insulin: studies in vitro and in vivo. Rev Cienc Farm Basica Apl 2008; 29: 239-244.
39. Mallikarjuna Reddy K, et al,. Temperature sensitive semi-IPN microspheres from sodium alginate and N-isopropylacrylamide for controlled release of 5-fluorouracil. J Appl Polym Sci 2008; 107: 2820-2829. (Pubitemid 351238709)
40. Sanli O, et al,. Release characteristics of diclofenac sodium from poly(vinyl alcohol)/sodium alginate and poly(vinyl alcohol)-grafted- poly(acrylamide)/sodium alginate blend beads. Eur J Pharm Biopharm 2007; 65: 204-214. (Pubitemid 46043423)
41. Shi J, et al,. Drug release of pH/temperature-responsive calcium alginate/poly(N-isopropylacrylamide) semi-IPN beads. Macromol Biosci 2006; 6: 358-363. (Pubitemid 43829064)
42. Shi J, et al,. Chitosan coated alginate beads containing poly(N-isopropylacrylamide) for dual-stimuli-responsive drug release. J Biomed Mater Res B Appl Biomater 2008; 84: 595-603.
43. ShimarizaAshikin WHN, et al,. Plasticity of hot air-dried mannuronate- and guluronate-rich alginate films. Carbohydr Polym 2010; 81: 104-113.
44. Zhao S, et al,. Synthesis and characterization of thermo-sensitive semi-IPN hydrogels based on poly(ethylene glycol)-co-poly(ε-caprolactone) macromer, N-isopropylacrylamide, and sodium alginate. Carbohydr Res 2010; 345: 425-431.
45. Coppi G, Iannuccelli V,. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system. Int J Pharm 2009; 367: 127-132.
46. Crcarevska MS, et al,. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur J Pharm Biopharm 2008; 68: 565-578.
47. Dodov MG, et al,. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization. Int J Pharm 2009; 381: 166-175.
48. Liu P, Krishnan TR,. Alginate-pectin-poly-l-lysine particulate as a potential controlled release formulation. J Pharm Pharmacol 1999; 51: 141-149. (Pubitemid 29131306)
49. Mladenovska K, et al,. Colon specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Int J Pharm 2007; 342: 124-136. (Pubitemid 47259341)
50. Pandey R, Khuller GK,. Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers. J Antimicrob Chemother 2004; 53: 635-640. (Pubitemid 38499780)
51. Ribeiro AJ, et al,. Chitosan-reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur J Pharm Sci 2005; 25: 31-40. (Pubitemid 40602193)
52. Silva CM, et al,. Microencapsulation of hemoglobin in chitosan-coated alginate microspheres prepared by emulsification/internal gelation. AAPS J 2006; 7: E903-E913. Article 88.
53. Tan T-W, et al,. Release behaviour of ketoprofen from chitosan/alginate microcapsules. J Bioact Compat Polym 2003; 18: 207-218. (Pubitemid 37021498)
54. Tapia C, et al,. Microencapsulation by spray coagulation of diltiazem HCl in calcium alginate-coated chitosan. AAPS PharmSciTech 2008; 9: 1198-1206.
55. Ye S, et al,. Deposition temperature effect on release rate of indomethacin microcrystals from microcapsules of layer-by-layer assembled chitosan and alginate multilayer films. J Controlled Release 2005; 106: 319-328. (Pubitemid 41187441)
56. Yu C-Y, et al,. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems. Int J Pharm 2008; 357: 15-21.
57. Yu C-Y, et al,. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property. Colloids Surf B Biointerfaces 2009; 68: 245-249.
58. Zhao Q, et al,. Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studies. Nanomedicine 2007; 3: 63-74. (Pubitemid 46437316)
59. Zheng CH, et al,. Optimization and characterization of chitosan-coated alginate microcapsules containing albumin. Pharmazie 2005; 60: 434-438. (Pubitemid 40966299)
60. Das RK, et al,. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 2010; 6: 153-160.
61. Douglas KL, Tabrizian M,. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym Ed 2005; 16: 43-56. (Pubitemid 41149195)
62. Haidar ZS, et al,. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials 2008; 29: 1207-1215.
63. Reis CP, et al,. Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery. Drug Deliv 2008; 15: 127-139. (Pubitemid 351302237)
64. Anal AK, et al,. Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein. Drug Dev Ind Pharm 2003; 29: 713-724. (Pubitemid 36835163)
65. Anal AK, Stevens WF,. Chitosan-alginate multilayer beads for controlled release of ampicillin. Int J Pharm 2005; 290: 45-54. (Pubitemid 40139043)
66. Basu SK, Rajendran A,. Studies in the development of nateglinide loaded calcium alginate and chitosan coated calcium alginate beads. Chem Pharm Bull 2008; 56: 1077-1084.
67. Cruz MCP, et al,. Evaluation of the diffusion coefficient for controlled release of oxytetracycline from alginate/chitosan/poly(ethylene glycol) microbeads in simulated gastrointestinal environments. Biotechnol Appl Biochem 2004; 40: 243-253. (Pubitemid 39627192)
68. Dai Y-N, et al,. Swelling characteristics and drug delivery properties of nifedipine-loaded pH sensitive alginate-chitosan hydrogel beads. J Biomed Mater Res B Appl Biomater 2008; 86: 493-500.
69. Elizathary AA, et al,. Evaluation of alginate-chitosan bioadhesive beads as a drug delivery system for the controlled release of theophylline. J Appl Polym Sci 2009; 111: 2452-2459.
70. Shi X, et al,. Polyelectrolyte complex beads composed of water-soluble chitosan/alginate: characterization and their protein release behavior. J Appl Polym Sci 2006; 100: 4614-4622.
71. Wong TW,. Use of microwave in processing of drug delivery systems. Curr Drug Deliv 2008; 5: 77-84. (Pubitemid 351536312)
72. Wong TW, et al,. Design of controlled-release solid dosage forms of alginate and chitosan using microwave. J Controlled Release 2002; 84: 99-114. (Pubitemid 35439141)
73. Wong TW, et al,. Aging and microwave effects on alginate/chitosan matrices. J Controlled Release 2005; 104: 461-475.
74. Xu Y, et al,. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. Int J Pharm 2007; 336: 329-337. (Pubitemid 46670661)
75. Abdelbary GA, Tadros MI,. Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm Biopharm 2008; 69: 1019-1028.
76. Tapia C, et al,. Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems. Eur J Pharm Biopharm 2004; 57: 65-75. (Pubitemid 38058804)
77. Tapia C, et al,. Study of the release mechanism of diltiazem hydrochloride from matrices bases on chitosan-alginate and chitosan-carrageenan mixtures. Biomacromolecules 2005; 6: 2389-2395. (Pubitemid 41388248)
78. Abreu FOMS, et al,. Preparation and properties of core-shell alginate-carboxymethylchitosan hydrogels. Polym Int 2009; 58: 1267-1274.
79. Cafaggi S, et al,. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Controlled Release 2007; 121: 110-123. (Pubitemid 47161043)
80. Dai Y-N, et al,. A novel pH sensitive N-succinyl chitosan/alginate hydrogel bead for nifedipine delivery. Biopharm Drug Disposition 2008; 29: 173-184. (Pubitemid 351722162)
81. El-sherbiny IM,. Enhanced pH-responsive carrier system based on alginate and chemically modified carboxymethyl chitosan for oral delivery of protein drugs: preparation and in-vitro assessment. Carbohydr Polym 2010; 80: 1125-1136.
82. Li T, et al,. Quaternized chitosan/alginate nanoparticles for protein delivery. J Biomed Mater Res A 2007; 83: 383-390. (Pubitemid 47557387)
83. Lin Y-H, et al,. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 2005; 26: 2105-2113. (Pubitemid 39575353)
84. Tavakol M, et al,. Sulfasalazine release from alginate-N,O-carboxymethyl chitosan gel beads coated by chitosan. Carbohydr Polym 2009; 77: 326-330.
85. Wang Q, et al,. Preparation and swelling properties of pH-sensitive composite hydrogel beads based on chitosan-g-poly(acrylic acid)/vermiculite and sodium alginate for diclofenac controlled release. Int J Biol Macromol 2010; 46: 356-362.
86. Wang Q, et al,. Preparation and characterization of a novel pH-sensitive chitosan-g-poly(acrylic acid)/attapulgite/sodium alginate composite hydrogel bead for controlled release of diclofenac sodium. Carbohydr Polym 2009; 78: 731-737.
87. Wong TW,. Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formulat 2009; 3: 8-25.
88. Halder A, et al,. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex. Int J Pharm 2005; 302: 84-94. (Pubitemid 41244818)
89. Halder A, et al,. Development and evaluation of polyethyleneimine-treated calcium alginate beads for sustained release of diltiazem. J Microencapsul 2005; 22: 67-80. (Pubitemid 40774996)
90. Setty CM, et al,. Alginate-coated alginate-polyethyleneimine beads for prolonged release of furosemide in simulated intestinal fluid. Drug Dev Ind Pharm 2005; 31: 435-446. (Pubitemid 41289156)
91. Ferreiro MG, et al,. Alginate/poly-l-lysine microparticles for the intestinal delivery of antisense oligonucleotides. Pharm Res 2002; 19: 755-764.
92. Rajaonarivony M, et al,. Development of a new drug carrier made from alginate. J Pharm Sci 1993; 82: 912-917. (Pubitemid 23317253)
93. Wang S-B, et al,. Novel alginate-poly(l-histidine) microcapsules as drug carriers: in vitro protein release and short term stability. Macromol Biosci 2005; 5: 408-414. (Pubitemid 40813977)
94. Zhang J-P, et al,. Preparation and swelling properties of pH-sensitive sodium alginate/layered double hydroxides hybrid beads for controlled release of diclofenac sodium. J Biomed Mater Res B Appl Biomater 2010; 92: 205-214.
95. Zhang J, et al,. In situ generation of sodium alginate/hydroxypatite nanocomposite beads as drug-controlled release matrices. Acta Biomater 2010; 6: 445-454.
96. Tada D, et al,. Albumin-crosslinked alginate hydrogels as sustained drug release carrier. Mater Sci Eng 2007; 27: 870-874. (Pubitemid 46617262)
97. Almeida PF, Almeida AJ,. Cross-linked alginate-gelatine beads: a new matrix for controlled release of pindolol. J Controlled Release 2004; 97: 431-439. (Pubitemid 38802945)
98. Saravanan M, Rao KP,. Pectin-gelatin and alginate-gelatin complex coacervation for controlled drug delivery: influence of anionic polysaccharides and drugs being encapsulated on physicochemical properties of microcapsules. Carbohydr Polym 2010; 80: 808-816.
99. Tapia C, et al,. Study of dissolution behavior of matrices tablets based on alginate-gelatin mixtures as prolonged diltiazem hydrochloride release systems. Drug Dev Ind Pharm 2007; 33: 585-593. (Pubitemid 47035887)
100. Moustafine RI, et al,. Interpolyelectrolyte complexes of Eudragit E PO with sodium alginate as potential carriers for colonic drug delivery: monitoring of structural transformation and composition changes during swellability and release evaluating. Drug Dev Ind Pharm 2009; 35: 1439-1451.
101. Scocca S, et al,. Alginate/polymethacrylate copolymer microparticles for the intestinal delivery of enzymes. Curr Drug Deliv 2007; 4: 103-108. (Pubitemid 46557486)
102. Sonavane GS, Devarajan PV,. Preparation of alginate nanoparticles using Eudragit E100 as a new complexing agent: development, In-vitro, and in-vivo evaluation. J Biomed Nanotechnol 2007; 3: 160-169. (Pubitemid 351877165)
103. Huang L, et al,. A novel insulin oral delivery system assisted by cationic β-cyclodextrin polymers. J Appl Polym Sci 2010; 115: 1371-1379.
104. Pongjanyakul T, et al,. Modulation of drug release from glyceryl palmitostearate-alginate beads via heat treatment. Int J Pharm 2006; 319: 20-28. (Pubitemid 44051798)
105. Gombotz WR, Wee SF,. Protein release from alginate matrices. Adv Drug Deliv Rev 1998; 31: 267-285. (Pubitemid 28191869)
106. Takka S, Acarturk F,. Calcium alginate microparticles for oral administration. I: effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul 1999; 16: 275-290. (Pubitemid 29191812)
107. Ching AL, et al,. Modifying matrix micro-environmental pH to achieve sustained drug release from highly laminating alginate matrices. Eur J Pharm Sci 2008; 33: 361-370.
108. Liew CV, et al,. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm 2006; 309: 25-37. (Pubitemid 43129461)
109. Sriamornsak P, et al,. Swelling, erosion and release behavior of alginate-based matrix tablets. Eur J Pharm Biopharm 2007; 66: 435-450. (Pubitemid 46756227)
110. Sriamornsak P, et al,. Alginate-based pellets prepared by extrusion-spheronization: effect of the amount and type of sodium alginate and calcium salts. Eur J Pharm Biopharm 2008; 69: 274-284. (Pubitemid 351467156)
111. Radman EM, Wong TW,. Effects of microwave on drug release responses of spray-dried alginate microspheres. Drug Dev Ind Pharm 2010; 36: 1149-1167.
112. Sirkiä T, et al,. Biopharmaceutical evaluation of new prolonged-release press-coated ibuprofen tablets containing sodium alginate to adjust drug release. Int J Pharm 1994; 107: 179-187. (Pubitemid 24182102)
113. Veski P, Marvola M,. Sodium alginates as diluents in hard gelatin capsules containing ibuprofen as a model drug. Pharmazie 1993; 48: 757-760. (Pubitemid 23327175)
114. Lin H, et al,. Synthesis and characterization of pH- and salt-responsive hydrogels based on etherificated sodium alginate. J Appl Polym Sci 2010; 115: 3161-3167.
115. Nurulaini H, Wong TW,. Design of in-situ dispersible and calcium crosslinked alginate pellets as intestinal-specific drug carrier by melt pelletization technique. J Pharm Sci 2011; 100: 2248-2257.
116. Berthiaux H, et al,. Continuous mixing of powder mixtures with pharmaceutical process constraints. Chem Eng Process 2008; 47: 2315-2322.
117. Aissa AA, et al,. Polymer powder mixing part I: mixing characterization in rotating cylinders. Chem Eng Sci 2010; 65: 786-795.
118. Choi KS, et al,. Experimental study on electrostatic charging of polymer powders in mixing processes. J Loss Prevent Proc Ind 2010; 23: 594-600.
119. Kim JH, et al,. Rapid temperature/pH response of porous alginate-g-poly(N-isopropylacrylamide) hydrogels. Polymer 2002; 43: 7549-7558. (Pubitemid 35364727)
120. Sang BL, et al,. Preparation of alginate/poly(N-isopropylacrylamide) hydrogels using gamma-ray irradiation grafting. Macromol Res 2004; 12: 269-275. (Pubitemid 38901242)
121. Yang W, et al,. Synthesis and characterization of MMA-NaAlg/ hydroxyapatite composite and the interface analyse with molecular dynamics. Carbohydr Polym 2009; 77: 331-337.
122. Babak VG, et al,. Hydrophobically associating alginate derivatives: surface tension properties of their mixed aqueous solutions with oppositely charged surfactants. J Colloid Interface Sci 2000; 225: 505-510. (Pubitemid 30313930)
123. Leonard M, et al,. Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties. J Controlled Release 2004; 98: 395-405. (Pubitemid 39093950)
124. Pelletier S, et al,. Amphiphilic derivatives of sodium alginate and hyaluronate: synthesis and physico-chemical properties of aqueous dilute solutions. Carbohydr Polym 2000; 43: 343-349.
125. Broderick E, et al,. The characterisation of a novel, covalently modified, amphiphilic alginate derivative, which retains gelling and non-toxic properties. J Colloid Interface Sci 2006; 298: 154-161.
126. Vallée F, et al,. Synthesis and rheological properties of hydrogels based on amphiphilic alginate-amide derivatives. Carbohydr Res 2009; 344: 223-228.
127. Callewaert M, et al,. Albumin-alginate-coated microspheres: resistance to steam sterilization and to lyophilization. Int J Pharm 2007; 344: 161-164. (Pubitemid 47464821)
128. Edwards-Lévy F, Lévy M-C,. Serum albumin-alginate coated beads: mechanical properties and stability. Biomaterials 1999; 20: 2069-2084. (Pubitemid 29447629)
129. Gray CJ, et al,. Studies on the chemical stability of propylene glycol alginate esters. Carbohydr Polym 1990; 12: 419-430. (Pubitemid 20669229)
130. Hurteaux R, et al,. Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide. Eur J Pharm Sci 2005; 24: 187-197. (Pubitemid 40127549)
131. 2O with sodium alginate grafted sodium acrylate. Thermochim Acta 2007; 463: 18-20. (Pubitemid 47418106)
132. Wang W, Wang A,. Synthesis and swelling properties of pH-sensitive semi-IPN superabsorbent hydrogels based on sodium alginate-g-poly(sodium acrylate) and polyvinylpyrrolidone. Carbohydr Polym 2010; 80: 1028-1036.
133. Pourjavadi A, et al,. Partially hydrolysed crosslinked alginate-graft-polymethacrylamide as a novel biopolymer-based superabsorbent hydrogel having pH-responsive properties. Macromol Res 2005; 13: 45-53. (Pubitemid 40342110)
134. Marandi GB, et al,. Synthesis of an alginate-poly(sodium acrylate-co-acrylamide) superabsorbent hydrogel with low salt sensitivity and high pH sensitivity. J Appl Polym Sci 2006; 101: 2927-2937. (Pubitemid 44220927)
135. Gomez CG, et al,. Synthesis and characterization of a β-CD-alginate conjugate. Polymer 2006; 47: 8509-8516.
136. Pluemsab W, et al,. Synthesis and inclusion property of α-cyclodextrin-linked alginate. Polymer 2005; 46: 9778-9783. (Pubitemid 41455209)
137. Bardajee GR, et al,. Irradiation synthesis of biopolymer-based superabsorbent hydrogel: optimization using the Taguchi method and investigation of its swelling behavior. Adv Polym Technol 2009; 28: 131-140.
138. Kulkarni RV, Sa B,. Novel pH-sensitive interpenetrating network hydrogel beads of carboxymethylcellulose-(polyacrylamide-grafted-alginate) for controlled release of ketoprofen: preparation and characterization. Curr Drug Deliv 2008; 5: 256-264.
139. Kulkarni RV, Sa B,. Polyacrylamide-grafted-alginate-based pH-sensitive hydrogel beads for delivery of ketoprofen to the intestine: in vitro and in vivo evaluation. J Biomater Sci 2009; 20: 235-251.
140. Kulkarni RV, et al,. Polyacrylamide-g-alginate-based electrically responsive hydrogel for drug delivery application: synthesis, characterization, and formulation development. J Appl Polym Sci 2010; 115: 1180-1188.
141. Toti US, Aminabhavi TM,. Synthesis and characterization of polyacrylamide grafted sodium alginate membranes for pervaporation separation of water + isopropanol mixtures. J Appl Polym Sci 2004; 92: 2030-2037. (Pubitemid 38517734)
142. Isiklan N, et al,. Synthesis and characterization of poly(N-vinyl-2- pyrrolidone) grafted sodium alginate hydrogel beads for the controlled release of indomethacin. J Appl Polym Sci 2008; 110: 481-493.
143. Laurienzo P, et al,. Synthesis and characterization of a novel alginate-poly(ethylene glycol) graft copolymer. Carbohydr Polym 2005; 62: 274-282. (Pubitemid 41737572)
144. Kim B-Y, et al,. Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system. J Controlled Release 2005; 102: 525-538. (Pubitemid 40170197)
145. Sultzbaugh KJ, Speaker TJ,. A method to attach lectins to the surface of spermine alginate microcapsules based on the avidin biotin interaction. J Microencapsul 1996; 13: 363-376. (Pubitemid 26232317)
146. Bernkop-Schnürch A, et al,. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Controlled Release 2001; 71: 277-285. (Pubitemid 32276047)
147. Freeman I, et al,. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 2008; 29: 3260-3268.
148. Taha MO, et al,. Synthesis of zinc-crosslinked thiolated alginic acid beads and their in vitro evaluation as potential enteric delivery system with folic acid as model drug. Pharmazie 2005; 60: 736-742. (Pubitemid 41501215)
149. Donati I, et al,. Galactose-substituted alginate: preliminary characterization and study of gelling properties. Biomacromolecules 2003; 4: 624-631. (Pubitemid 36701232)
150. Yang J, et al,. Galactosylated alginate as a scaffold for hepatocytes entrapment. Biomaterials 2002; 23: 471-479. (Pubitemid 33051035)
151. Morgan SM, et al,. Alginates as drug carriers: covalent attachment of alginates to therapeutic agents containing primary amine groups. Int J Pharm 1995; 122: 121-128.